Prostate Cancer, Version 1.2014

View More View Less
  • 1 From Roswell Park Cancer Institute; Dana-Farber/Brigham and Women’s Cancer Center; Duke Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Huntsman Cancer Institute at the University of Utah; Memorial Sloan-Kettering Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; Prostate Health Education Network; University of Washington/Seattle Cancer Care Alliance; Fox Chase Cancer Center; City of Hope Comprehensive Cancer Center; Massachusetts General Hospital Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Vanderbilt-Ingram Cancer Center; University of Michigan Comprehensive Cancer Center; Moffitt Cancer Center; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Patient Advocate; Stanford Cancer Institute; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and National Comprehensive Cancer Network.
Restricted access

The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer. This report highlights notable recent updates. Radium-223 dichloride is a first-in-class radiopharmaceutical that recently received approval for the treatment of patients with symptomatic bone metastases and no known visceral disease. It received a category 1 recommendation as both a first-line and second-line option. The NCCN Prostate Cancer Panel also revised recommendations on the choice of intermittent or continuous androgen deprivation therapy based on recent phase III clinical data comparing the 2 strategies in the nonmetastatic and metastatic settings.

Supplementary Materials

    • Supplemental Material (PDF 180 KB)
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 330 182 13
PDF Downloads 47 24 3
EPUB Downloads 0 0 0